Microarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: Identification of genes related to disease progression

Japanese Journal of Cancer Research

Volumn 93, Issue 8, 2002, Pages 894-901

  Nishiu, Mieko ^a   Yanagawa, Rempei ^b   Nakatsuka, Shin Ichi ^a   Yao, Masayuki ^a   Tsunoda, Tatsuhiko ^c   Nakamura, Yusuke ^b   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Diffuse large B cell lymphoma; Expression profile; Microarray; Progression; Stage

Indexed keywords

AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CAVEOLIN; CELL ADHESION MOLECULE; CELL CYCLE PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LECTIN RECEPTOR; NUCLEAR PROTEIN; PHOSPHOSERINE; PREDNISOLONE; PROTEIN S 100; THERARUBICIN; TUMOR MARKER; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA MICROARRAY; DRUG TARGETING; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0036670219     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01335.x     Document Type: Article

References (28)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
2. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of comparison with the Working Formulation
3. A predictive model for aggressive non-Hodgkin's lymphoma
4. Report of the committee on Hodgkin's disease staging classification
5. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma
6. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
7. Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma
8. CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor
9. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial
10. Use of a cDNA microarray to analyse gene expression patterns in human cancer
11. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
12. Gene expression profiles of laser-captured adjacent neuronal subtypes
13. Cloning of cDNA for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope
14. Molecular cloning of a human cDNA homologous to CDC10 in Saccharomyces cerevisiae
15. The budding yeast U5 snRNP Prp8 is a highly conserved protein which links RNA splicing with cell cycle progression
16. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc
17. Pontin 52 an interaction partner of beta-catenin binds to the TATA box binding protein
18. Cerebellar bata 2-chimaerin, a GTPase-activating protein for p2l ras-related rac is specifically expressed in granule cells and has a unique N-terminal SH2 domain
19. RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase
20. Enzymes of serine metabolism in normal developing and neoplastic rat tissues
21. Suppression of tumorigenicity in Ras-transformed fibroblasts by alpha 2(I) collagen
22. Loss of type VI collagen in experimental and most spontaneous human fibrosarcomas
23. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family
24. Gene trapping identifies inhibitors of oncogenic transformation. The tissue inhibitor of metalloproteinases-3 (TIMP3) and collagen type I alpha2 (COL1A2) are epidermal growth factor-regulated growth repressors
25. DANCE a novel secreted RGD protein expressed in developing, atherosclerotic and balloon-injured arteries
26. APCs express DCIR a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif
27. Molecular genetics of the caveolin gene family: Implications for human cancers diabetes Alzheimer disease and muscular dystrophy
28. Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL